Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 12 entries
Sorted by: Best Match Show Resources per page
Heart rate variability during head-up tilt test in patients with syncope of unknown origin.

Kardiologia polska

Gielerak G, Makowski K, Kramarz E, Cholewa M, Dłuzniewska E, Roszczyk A, Bogaj A.
PMID: 12961000
Kardiol Pol. 2002 Nov;57(11):399-406.

BACKGROUND: Analysis of pathophysiological mechanisms responsible for vaso-vagal reaction reveals a close relationship between neurocardiogenic syncope and the preceding abnormalities of autonomic nervous system (ANS). Therefore, the interest in the assessment of heart rate variability (HRV) for detecting and...

Cite
Gielerak G, Makowski K, Kramarz E, et al. Heart rate variability during head-up tilt test in patients with syncope of unknown origin. Kardiol Pol. 2002;57(11):399-406
Gielerak, G., Makowski, K., Kramarz, E., Cholewa, M., Dłuzniewska, E., Roszczyk, A., & Bogaj, A. (2002). Heart rate variability during head-up tilt test in patients with syncope of unknown origin. Kardiologia polska, 57(11), 399-406.
Gielerak, Grzegorz, et al. "Heart rate variability during head-up tilt test in patients with syncope of unknown origin." Kardiologia polska vol. 57,11 (2002): 399-406.
Gielerak G, Makowski K, Kramarz E, Cholewa M, Dłuzniewska E, Roszczyk A, Bogaj A. Heart rate variability during head-up tilt test in patients with syncope of unknown origin. Kardiol Pol. 2002 Nov;57(11):399-406. Polish. PMID: 12961000.
Copy Download .nbib Format: NLM
[Noninvasive characterization of a case of Danon disease].

Revista espanola de cardiologia

Braksator W, Chybowska B, Kuch M, Dluzniewski M.
PMID: 20334819
Rev Esp Cardiol. 2010 Apr;63(4):493-5.

No abstract available.

Cite
Braksator W, Chybowska B, Kuch M, et al. Caracterización no invasiva de un caso de enfermedad de Danon. [Noninvasive characterization of a case of Danon disease]. Rev Esp Cardiol. 2010;63(4):493-5
Braksator, W., Chybowska, B., Kuch, M., & Dluzniewski, M. (2010). Caracterización no invasiva de un caso de enfermedad de Danon. [Noninvasive characterization of a case of Danon disease]. Revista espanola de cardiologia, 63(4), 493-5.
Braksator, Wojciech, et al. "Caracterización no invasiva de un caso de enfermedad de Danon." [Noninvasive characterization of a case of Danon disease]. Revista espanola de cardiologia vol. 63,4 (2010): 493-5.
Braksator W, Chybowska B, Kuch M, Dluzniewski M. Caracterización no invasiva de un caso de enfermedad de Danon. [Noninvasive characterization of a case of Danon disease]. Rev Esp Cardiol. 2010 Apr;63(4):493-5. Spanish. PMID: 20334819.
Copy Download .nbib Format: NLM
Epoxy matrix with triaromatic mesogenic unit in dielectric spectroscopy observation.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy

Włodarska M, Mossety-Leszczak B, Bąk GW, Kisiel M, Dłużniewski M, Okrasa L.
PMID: 29328951
Spectrochim Acta A Mol Biomol Spectrosc. 2018 Apr 05;194:102-110. doi: 10.1016/j.saa.2018.01.001. Epub 2018 Jan 04.

No abstract available.

Cite
Włodarska M, Mossety-Leszczak B, Bąk GW, et al. Epoxy matrix with triaromatic mesogenic unit in dielectric spectroscopy observation. Spectrochim Acta A Mol Biomol Spectrosc. 2018;194:102-110doi: 10.1016/j.saa.2018.01.001.
Włodarska, M., Mossety-Leszczak, B., Bąk, G. W., Kisiel, M., Dłużniewski, M., & Okrasa, L. (2018). Epoxy matrix with triaromatic mesogenic unit in dielectric spectroscopy observation. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 194102-110. https://doi.org/10.1016/j.saa.2018.01.001
Włodarska, Magdalena, et al. "Epoxy matrix with triaromatic mesogenic unit in dielectric spectroscopy observation." Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy vol. 194 (2018): 102-110. doi: https://doi.org/10.1016/j.saa.2018.01.001
Włodarska M, Mossety-Leszczak B, Bąk GW, Kisiel M, Dłużniewski M, Okrasa L. Epoxy matrix with triaromatic mesogenic unit in dielectric spectroscopy observation. Spectrochim Acta A Mol Biomol Spectrosc. 2018 Apr 05;194:102-110. doi: 10.1016/j.saa.2018.01.001. Epub 2018 Jan 04. PMID: 29328951.
Copy Download .nbib Format: NLM
Use of negative control outcomes to assess the comparability of patients initiating lipid-lowering therapies.

Pharmacoepidemiology and drug safety

Levintow SN, Orroth KK, Breskin A, Park AS, Flores Arredondo JH, Dluzniewski P, Navar AM, Sørensen HT, Brookhart MA.
PMID: 34894377
Pharmacoepidemiol Drug Saf. 2021 Dec 11; doi: 10.1002/pds.5396. Epub 2021 Dec 11.

PURPOSE: Clinical trials have demonstrated efficacy of proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) in reducing risk of cardiovascular disease events, but effectiveness in routine clinical care has not been well-studied. We used negative control outcomes to assess potential...

Cite
Levintow SN, Orroth KK, Breskin A, et al. Use of negative control outcomes to assess the comparability of patients initiating lipid-lowering therapies. Pharmacoepidemiol Drug Saf. 2021;doi: 10.1002/pds.5396.
Levintow, S. N., Orroth, K. K., Breskin, A., Park, A. S., Flores Arredondo, J. H., Dluzniewski, P., Navar, A. M., Sørensen, H. T., & Brookhart, M. A. (2021). Use of negative control outcomes to assess the comparability of patients initiating lipid-lowering therapies. Pharmacoepidemiology and drug safety, . https://doi.org/10.1002/pds.5396
Levintow, Sara N, et al. "Use of negative control outcomes to assess the comparability of patients initiating lipid-lowering therapies." Pharmacoepidemiology and drug safety vol. (2021). doi: https://doi.org/10.1002/pds.5396
Levintow SN, Orroth KK, Breskin A, Park AS, Flores Arredondo JH, Dluzniewski P, Navar AM, Sørensen HT, Brookhart MA. Use of negative control outcomes to assess the comparability of patients initiating lipid-lowering therapies. Pharmacoepidemiol Drug Saf. 2021 Dec 11; doi: 10.1002/pds.5396. Epub 2021 Dec 11. PMID: 34894377.
Copy Download .nbib Format: NLM
Left Atrial Enlargement in Young High-Level Endurance Athletes - Another Sign of Athlete's Heart?.

Journal of human kinetics

Król W, Jędrzejewska I, Konopka M, Burkhard-Jagodzińska K, Klusiewicz A, Pokrywka A, Chwalbińska J, Sitkowski D, Dłużniewski M, Mamcarz A, Braksator W.
PMID: 28149413
J Hum Kinet. 2016 Oct 14;53:81-90. doi: 10.1515/hukin-2016-0012. eCollection 2016 Dec 01.

Enlargement of the left atrium is perceived as a part of athlete's heart syndrome, despite the lack of evidence. So far, left atrial size has not been assessed in the context of exercise capacity. The hypothesis of the present...

Cite
Król W, Jędrzejewska I, Konopka M, et al. Left Atrial Enlargement in Young High-Level Endurance Athletes - Another Sign of Athlete's Heart?. J Hum Kinet. 2016;53:81-90doi: 10.1515/hukin-2016-0012.
Król, W., Jędrzejewska, I., Konopka, M., Burkhard-Jagodzińska, K., Klusiewicz, A., Pokrywka, A., Chwalbińska, J., Sitkowski, D., Dłużniewski, M., Mamcarz, A., & Braksator, W. (2016). Left Atrial Enlargement in Young High-Level Endurance Athletes - Another Sign of Athlete's Heart?. Journal of human kinetics, 5381-90. https://doi.org/10.1515/hukin-2016-0012
Król, Wojciech, et al. "Left Atrial Enlargement in Young High-Level Endurance Athletes - Another Sign of Athlete's Heart?." Journal of human kinetics vol. 53 (2016): 81-90. doi: https://doi.org/10.1515/hukin-2016-0012
Król W, Jędrzejewska I, Konopka M, Burkhard-Jagodzińska K, Klusiewicz A, Pokrywka A, Chwalbińska J, Sitkowski D, Dłużniewski M, Mamcarz A, Braksator W. Left Atrial Enlargement in Young High-Level Endurance Athletes - Another Sign of Athlete's Heart?. J Hum Kinet. 2016 Oct 14;53:81-90. doi: 10.1515/hukin-2016-0012. eCollection 2016 Dec 01. PMID: 28149413; PMCID: PMC5260578.
Copy Download .nbib Format: NLM
Cardiac tumors: leiomyosarcoma - a case report.

Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery

Gierlak W, Syska-Sumińska J, Zieliński P, Dłużniewski M, Sadowski J.
PMID: 26702284
Kardiochir Torakochirurgia Pol. 2015 Sep;12(3):251-4. doi: 10.5114/kitp.2015.54464. Epub 2015 Sep 28.

We present a case report of a 60-year-old woman with a long history of leiomyosarcoma in different locations. She was admitted to the clinic due to a left ventricular tumor diagnosed in ECHO examination. The patient was qualified for...

Cite
Gierlak W, Syska-Sumińska J, Zieliński P, et al. Cardiac tumors: leiomyosarcoma - a case report. Kardiochir Torakochirurgia Pol. 2015;12(3):251-4doi: 10.5114/kitp.2015.54464.
Gierlak, W., Syska-Sumińska, J., Zieliński, P., Dłużniewski, M., & Sadowski, J. (2015). Cardiac tumors: leiomyosarcoma - a case report. Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery, 12(3), 251-4. https://doi.org/10.5114/kitp.2015.54464
Gierlak, Włodzimierz, et al. "Cardiac tumors: leiomyosarcoma - a case report." Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery vol. 12,3 (2015): 251-4. doi: https://doi.org/10.5114/kitp.2015.54464
Gierlak W, Syska-Sumińska J, Zieliński P, Dłużniewski M, Sadowski J. Cardiac tumors: leiomyosarcoma - a case report. Kardiochir Torakochirurgia Pol. 2015 Sep;12(3):251-4. doi: 10.5114/kitp.2015.54464. Epub 2015 Sep 28. PMID: 26702284; PMCID: PMC4631920.
Copy Download .nbib Format: NLM
Use of negative control outcomes to assess the comparability of patients initiating lipid-lowering therapies.

Pharmacoepidemiology and drug safety

Levintow SN, Orroth KK, Breskin A, Park AS, Flores-Arredondo JH, Dluzniewski P, Navar AM, Sørensen HT, Brookhart MA.
PMID: 34894377
Pharmacoepidemiol Drug Saf. 2021 Dec 11; doi: 10.1002/pds.5396. Epub 2021 Dec 11.

PURPOSE: Clinical trials have demonstrated efficacy of proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) in reducing risk of cardiovascular disease events, but effectiveness in routine clinical care has not been well-studied. We used negative control outcomes to assess potential...

Cite
Levintow SN, Orroth KK, Breskin A, et al. Use of negative control outcomes to assess the comparability of patients initiating lipid-lowering therapies. Pharmacoepidemiol Drug Saf. 2021;doi: 10.1002/pds.5396.
Levintow, S. N., Orroth, K. K., Breskin, A., Park, A. S., Flores-Arredondo, J. H., Dluzniewski, P., Navar, A. M., Sørensen, H. T., & Brookhart, M. A. (2021). Use of negative control outcomes to assess the comparability of patients initiating lipid-lowering therapies. Pharmacoepidemiology and drug safety, . https://doi.org/10.1002/pds.5396
Levintow, Sara N, et al. "Use of negative control outcomes to assess the comparability of patients initiating lipid-lowering therapies." Pharmacoepidemiology and drug safety vol. (2021). doi: https://doi.org/10.1002/pds.5396
Levintow SN, Orroth KK, Breskin A, Park AS, Flores-Arredondo JH, Dluzniewski P, Navar AM, Sørensen HT, Brookhart MA. Use of negative control outcomes to assess the comparability of patients initiating lipid-lowering therapies. Pharmacoepidemiol Drug Saf. 2021 Dec 11; doi: 10.1002/pds.5396. Epub 2021 Dec 11. PMID: 34894377.
Copy Download .nbib Format: NLM
Trends in Recurrent Coronary Heart Disease After Myocardial Infarction Among US Women and Men Between 2008 and 2017.

Circulation

Peters SAE, Colantonio LD, Dai Y, Zhao H, Bittner V, Farkouh ME, Dluzniewski P, Poudel B, Muntner P, Woodward M.
PMID: 32951451
Circulation. 2021 Feb 16;143(7):650-660. doi: 10.1161/CIRCULATIONAHA.120.047065. Epub 2020 Sep 21.

BACKGROUND: Rates for recurrent coronary heart disease (CHD) events have declined in the United States. However, few studies have assessed whether this decline has been similar among women and men.METHODS: Data were used from 770 408 US women and...

Cite
Peters SAE, Colantonio LD, Dai Y, et al. Trends in Recurrent Coronary Heart Disease After Myocardial Infarction Among US Women and Men Between 2008 and 2017. Circulation. 2020;143(7):650-660doi: 10.1161/CIRCULATIONAHA.120.047065.
Peters, S. A. E., Colantonio, L. D., Dai, Y., Zhao, H., Bittner, V., Farkouh, M. E., Dluzniewski, P., Poudel, B., Muntner, P., & Woodward, M. (2021). Trends in Recurrent Coronary Heart Disease After Myocardial Infarction Among US Women and Men Between 2008 and 2017. Circulation, 143(7), 650-660. https://doi.org/10.1161/CIRCULATIONAHA.120.047065
Peters, Sanne A E, et al. "Trends in Recurrent Coronary Heart Disease After Myocardial Infarction Among US Women and Men Between 2008 and 2017." Circulation vol. 143,7 (2021): 650-660. doi: https://doi.org/10.1161/CIRCULATIONAHA.120.047065
Peters SAE, Colantonio LD, Dai Y, Zhao H, Bittner V, Farkouh ME, Dluzniewski P, Poudel B, Muntner P, Woodward M. Trends in Recurrent Coronary Heart Disease After Myocardial Infarction Among US Women and Men Between 2008 and 2017. Circulation. 2021 Feb 16;143(7):650-660. doi: 10.1161/CIRCULATIONAHA.120.047065. Epub 2020 Sep 21. PMID: 32951451.
Copy Download .nbib Format: NLM
Use of negative control outcomes to assess the comparability of patients initiating lipid-lowering therapies.

Pharmacoepidemiology and drug safety

Levintow SN, Orroth KK, Breskin A, Park AS, Arredondo JHF, Dluzniewski P, Navar AM, Sørensen HT, Brookhart MA.
PMID: 34894377
Pharmacoepidemiol Drug Saf. 2021 Dec 11; doi: 10.1002/pds.5396. Epub 2021 Dec 11.

PURPOSE: Clinical trials have demonstrated efficacy of proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) in reducing risk of cardiovascular disease events, but effectiveness in routine clinical care has not been well-studied. We used negative control outcomes to assess potential...

Cite
Levintow SN, Orroth KK, Breskin A, et al. Use of negative control outcomes to assess the comparability of patients initiating lipid-lowering therapies. Pharmacoepidemiol Drug Saf. 2021;doi: 10.1002/pds.5396.
Levintow, S. N., Orroth, K. K., Breskin, A., Park, A. S., Arredondo, J. H. F., Dluzniewski, P., Navar, A. M., Sørensen, H. T., & Brookhart, M. A. (2021). Use of negative control outcomes to assess the comparability of patients initiating lipid-lowering therapies. Pharmacoepidemiology and drug safety, . https://doi.org/10.1002/pds.5396
Levintow, Sara N, et al. "Use of negative control outcomes to assess the comparability of patients initiating lipid-lowering therapies." Pharmacoepidemiology and drug safety vol. (2021). doi: https://doi.org/10.1002/pds.5396
Levintow SN, Orroth KK, Breskin A, Park AS, Arredondo JHF, Dluzniewski P, Navar AM, Sørensen HT, Brookhart MA. Use of negative control outcomes to assess the comparability of patients initiating lipid-lowering therapies. Pharmacoepidemiol Drug Saf. 2021 Dec 11; doi: 10.1002/pds.5396. Epub 2021 Dec 11. PMID: 34894377.
Copy Download .nbib Format: NLM
THE IMMEDIATE AND LONG-TERM EFFECTS OF KINESIOTAPE® ON BALANCE AND FUNCTIONAL PERFORMANCE.

International journal of sports physical therapy

Wilson V, Douris P, Fukuroku T, Kuzniewski M, Dias J, Figueiredo P.
PMID: 27104058
Int J Sports Phys Ther. 2016 Apr;11(2):247-53.

BACKGROUND: The application of Kinesio Tex® tape (KT) results, in theory, in the improvement of muscle contractibility by supporting weakened muscles. The effect of KT on muscle strength has been investigated by numerous researchers who have theorized that KT...

Cite
Wilson V, Douris P, Fukuroku T, et al. THE IMMEDIATE AND LONG-TERM EFFECTS OF KINESIOTAPE® ON BALANCE AND FUNCTIONAL PERFORMANCE. Int J Sports Phys Ther. 2016;11(2):247-53
Wilson, V., Douris, P., Fukuroku, T., Kuzniewski, M., Dias, J., & Figueiredo, P. (2016). THE IMMEDIATE AND LONG-TERM EFFECTS OF KINESIOTAPE® ON BALANCE AND FUNCTIONAL PERFORMANCE. International journal of sports physical therapy, 11(2), 247-53.
Wilson, Victoria, et al. "THE IMMEDIATE AND LONG-TERM EFFECTS OF KINESIOTAPE® ON BALANCE AND FUNCTIONAL PERFORMANCE." International journal of sports physical therapy vol. 11,2 (2016): 247-53.
Wilson V, Douris P, Fukuroku T, Kuzniewski M, Dias J, Figueiredo P. THE IMMEDIATE AND LONG-TERM EFFECTS OF KINESIOTAPE® ON BALANCE AND FUNCTIONAL PERFORMANCE. Int J Sports Phys Ther. 2016 Apr;11(2):247-53. PMID: 27104058; PMCID: PMC4827367.
Copy Download .nbib Format: NLM
Echocardiographic assessment of right ventricle adaptation to endurance training in young rowers - speckle tracking echocardiography.

Biology of sport

Konopka M, Krol W, Burkhard-Jagodzinska K, Jakubiak A, Klusiewicz A, Chwalbinska J, Pokrywka A, Sitkowski D, Dluzniewski M, Braksator W.
PMID: 28090137
Biol Sport. 2016 Dec;33(4):335-343. doi: 10.5604/20831862.1216659. Epub 2016 Sep 03.

The aim of this study was to determine the relationship between the degree of cardiorespiratory fitness and the function of the right ventricle (RV). 117 rowers, age 17.5±1.5 years. All subjects underwent cardiopulmonary exercise. Standard echocardiography and 2D speckle...

Cite
Konopka M, Krol W, Burkhard-Jagodzinska K, et al. Echocardiographic assessment of right ventricle adaptation to endurance training in young rowers - speckle tracking echocardiography. Biol Sport. 2016;33(4):335-343doi: 10.5604/20831862.1216659.
Konopka, M., Krol, W., Burkhard-Jagodzinska, K., Jakubiak, A., Klusiewicz, A., Chwalbinska, J., Pokrywka, A., Sitkowski, D., Dluzniewski, M., & Braksator, W. (2016). Echocardiographic assessment of right ventricle adaptation to endurance training in young rowers - speckle tracking echocardiography. Biology of sport, 33(4), 335-343. https://doi.org/10.5604/20831862.1216659
Konopka, M, et al. "Echocardiographic assessment of right ventricle adaptation to endurance training in young rowers - speckle tracking echocardiography." Biology of sport vol. 33,4 (2016): 335-343. doi: https://doi.org/10.5604/20831862.1216659
Konopka M, Krol W, Burkhard-Jagodzinska K, Jakubiak A, Klusiewicz A, Chwalbinska J, Pokrywka A, Sitkowski D, Dluzniewski M, Braksator W. Echocardiographic assessment of right ventricle adaptation to endurance training in young rowers - speckle tracking echocardiography. Biol Sport. 2016 Dec;33(4):335-343. doi: 10.5604/20831862.1216659. Epub 2016 Sep 03. PMID: 28090137; PMCID: PMC5143768.
Copy Download .nbib Format: NLM
Trends in Recurrent Coronary Heart Disease After Myocardial Infarction Among US Women and Men Between 2008 and 2017.

Circulation

Peters SAE, Colantonio LD, Dai Y, Zhao H, Bittner V, Farkouh ME, Dluzniewski P, Poudel B, Muntner P, Woodward M.
PMID: 32951451
Circulation. 2021 Feb 16;143(7):650-660. doi: 10.1161/CIRCULATIONAHA.120.047065. Epub 2020 Sep 21.

BACKGROUND: Rates for recurrent coronary heart disease (CHD) events have declined in the United States. However, few studies have assessed whether this decline has been similar among women and men.METHODS: Data were used from 770 408 US women and...

Cite
Peters SAE, Colantonio LD, Dai Y, et al. Trends in Recurrent Coronary Heart Disease After Myocardial Infarction Among US Women and Men Between 2008 and 2017. Circulation. 2020;143(7):650-660doi: 10.1161/CIRCULATIONAHA.120.047065.
Peters, S. A. E., Colantonio, L. D., Dai, Y., Zhao, H., Bittner, V., Farkouh, M. E., Dluzniewski, P., Poudel, B., Muntner, P., & Woodward, M. (2021). Trends in Recurrent Coronary Heart Disease After Myocardial Infarction Among US Women and Men Between 2008 and 2017. Circulation, 143(7), 650-660. https://doi.org/10.1161/CIRCULATIONAHA.120.047065
Peters, Sanne A E, et al. "Trends in Recurrent Coronary Heart Disease After Myocardial Infarction Among US Women and Men Between 2008 and 2017." Circulation vol. 143,7 (2021): 650-660. doi: https://doi.org/10.1161/CIRCULATIONAHA.120.047065
Peters SAE, Colantonio LD, Dai Y, Zhao H, Bittner V, Farkouh ME, Dluzniewski P, Poudel B, Muntner P, Woodward M. Trends in Recurrent Coronary Heart Disease After Myocardial Infarction Among US Women and Men Between 2008 and 2017. Circulation. 2021 Feb 16;143(7):650-660. doi: 10.1161/CIRCULATIONAHA.120.047065. Epub 2020 Sep 21. PMID: 32951451.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 12 entries